Patents by Inventor Edward M. Kaye

Edward M. Kaye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20230038956
    Abstract: The present disclosure provides, among other things, improved compositions and methods for treating muscular dystrophy. For example, the disclosure provides methods for treating Duchenne muscular dystrophy patients having a mutation in the DMD gene that is amenable to exon 53 skipping by administering an effective amount of golodirsen.
    Type: Application
    Filed: August 31, 2018
    Publication date: February 9, 2023
    Applicant: SAREPTA THERAPEUTICS, INC.
    Inventor: Edward M. KAYE
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20220403385
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: January 3, 2022
    Publication date: December 22, 2022
    Applicant: Sarepta Therapeutics, Inc.
    Inventor: Edward M. KAYE
  • METHODS FOR TREATING MUSCULAR DYSTROPHY WITH CASIMERSEN
    Publication number: 20220152086
    Abstract: The present disclosure provides, among other things, improved compositions and methods for treating muscular dystrophy. For example, the disclosure provides methods for treating Duchenne muscular dystrophy patients having a mutation in the DMD gene that is amenable to exon 45 skipping by administering an effective amount of casimersen.
    Type: Application
    Filed: March 25, 2020
    Publication date: May 19, 2022
    Inventor: Edward M. Kaye
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20220033820
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: October 21, 2021
    Publication date: February 3, 2022
    Applicant: Sarepta Therapeutics, Inc.
    Inventor: Edward M. KAYE
  • METHODS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20210008095
    Abstract: The present disclosure provides, among other things, improved compositions and methods for treating muscular dystrophy. For example, the disclosure provides methods for treating Duchenne muscular dystrophy patients having a mutation in the DMD gene that is amenable to exon 51 skipping by administering an effective amount of eteplirsen.
    Type: Application
    Filed: July 20, 2020
    Publication date: January 14, 2021
    Applicant: Sarepta Therapeutics, Inc.
    Inventor: Edward M. KAYE
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20200040337
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: June 7, 2019
    Publication date: February 6, 2020
    Inventor: Edward M. KAYE
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20190359982
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 28, 2019
    Inventor: Edward M. KAYE
  • Compositions for treating muscular dystrophy
    Patent number: 10364431
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: July 30, 2019
    Assignee: Sarepta Therapeutics, Inc.
    Inventor: Edward M. Kaye
  • Compositions for treating muscular dystrophy
    Patent number: 10337003
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: July 2, 2019
    Assignee: Sarepta Therapeutics, Inc.
    Inventor: Edward M. Kaye
  • METHODS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20190054113
    Abstract: The present disclosure provides, among other things, improved compositions and methods for treating muscular dystrophy. For example, the disclosure provides methods for treating Duchenne muscular dystrophy patients having a mutation in the DMD gene that is amenable to exon 51 skipping by administering an effective amount of eteplirsen.
    Type: Application
    Filed: September 29, 2016
    Publication date: February 21, 2019
    Inventor: Edward M. KAYE
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20180105811
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: May 24, 2017
    Publication date: April 19, 2018
    Inventor: Edward M. KAYE
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20170283799
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: November 22, 2016
    Publication date: October 5, 2017
    Inventor: Edward M. KAYE
  • Compositions for treating muscular dystrophy
    Patent number: 9506058
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: November 29, 2016
    Assignee: Sarepta Therapeutics, Inc.
    Inventor: Edward M. Kaye
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20140329762
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: March 14, 2014
    Publication date: November 6, 2014
    Applicant: SAREPTA THERAPEUTICS, INC.
    Inventor: Edward M. KAYE
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20140315862
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 23, 2014
    Applicant: Sarepta Therapeutics, Inc.
    Inventor: Edward M. Kaye